GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd (SZSE:301130) » Definitions » EV-to-FCF

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co (SZSE:301130) EV-to-FCF : -19.96 (As of Mar. 25, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Jilin Province Xidian Pharmaceutical Sci-Tech Development Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Enterprise Value is ¥1,657.4 Mil. Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-83.1 Mil. Therefore, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's EV-to-FCF for today is -19.96.

The historical rank and industry rank for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's EV-to-FCF or its related term are showing as below:

SZSE:301130' s EV-to-FCF Range Over the Past 10 Years
Min: -217.31   Med: -16.59   Max: 157.41
Current: -20.89

During the past 11 years, the highest EV-to-FCF of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co was 157.41. The lowest was -217.31. And the median was -16.59.

SZSE:301130's EV-to-FCF is ranked worse than
100% of 549 companies
in the Drug Manufacturers industry
Industry Median: 23.27 vs SZSE:301130: -20.89

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-25), Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's stock price is ¥27.05. Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.550. Therefore, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's PE Ratio (TTM) for today is 49.18.


Jilin Province Xidian Pharmaceutical Sci-Tech Development Co EV-to-FCF Historical Data

The historical data trend for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co EV-to-FCF Chart

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Annual Data
Trend Dec12 Dec13 Dec14 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 133.83 -24.80

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.69 -24.80 -15.54 -15.63 -22.36

Competitive Comparison of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's EV-to-FCF falls into.



Jilin Province Xidian Pharmaceutical Sci-Tech Development Co EV-to-FCF Calculation

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1657.368/-83.051
=-19.96

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's current Enterprise Value is ¥1,657.4 Mil.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-83.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jilin Province Xidian Pharmaceutical Sci-Tech Development Co  (SZSE:301130) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=27.05/0.550
=49.18

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's share price for today is ¥27.05.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.550.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Jilin Province Xidian Pharmaceutical Sci-Tech Development Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Business Description

Traded in Other Exchanges
N/A
Address
No. 777, Xidian Street, Panshi Economic Development Zone, Jilin Province, Panshi, CHN, 132300
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd is mainly engaged in the research, development, production, and sales of chemical APIs and preparations. It is focused on the development and manufacturing of iron supplement preparations, circulatory disorder treatment drugs, anti-psychotic drugs, and APIs. The company's product portfolio comprises Compound Ferrous Sulfate Folic Acid Tablets, Risperidone Orally Disintegrating Tablets, Escitalopram Oxalate Tablets, Daphne Capsules, Zoledronic Acid for Injection, etc., and various APIs.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Headlines

No Headlines